TELA Bio market cap TELA
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 2, 2026
- $35.9M
- Highest close in our data
- $272.8M
- Jun 2023
TELA Bio is worth $35.9M at the close on Nov 2, 2026, at $0.80 a share.
That is down 23% over the last year and down 81% over five years.
Its highest close in our data was $272.8M in Jun 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $35.9M | $25.4M | $56.6M | −22% |
| 2025 | $46M | $37.8M | $114.6M | −60% |
| 2024 | $114.6M | $60.3M | $178.3M | −29% |
| 2023 | $162.1M | $113.1M | $272.8M | −26% |
| 2022 | $220.3M | $83.7M | $220.3M | +19% |
| 2021 | $185.6M | $176.6M | $236.7M | −14% |
| 2020 | $217.1M | $74.9M | $257.9M | +50% |
| 2019 | $144.3M | $137.6M | $144.3M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest TELA Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| TELATELA Bio | $35.9M |
| NEPHNephros | $35.2M |
| APTAlpha Pro Tech | $56.3M |
| KEQUKewaunee Scientific | $96.7M |
| PDEXPro DEX | $184.5M |
| UTMDUtah Medical Products | $224.6M |
| INFUInfuSystem | $275.7M |
| EMBCEmbecta | $350.7M |
| Peer median | $184.5M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on TELA Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.